Company / Assets per Share
Outlook Therapeutics, Inc. Assets per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Assets per Share
$0.78
FY2025
5-year range
$0.69 / $1.90
FY2021-FY2025
Trend
+12.7%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Assets per Share has fluctuated over the past 6 years, ranging from $0.69 in FY2020 to $2.51 in FY2016.
Based on SEC 10-K filings.
0.78 in FY2025 with a 5-year CAGR of +2.4%.
Declined from $1.90 to $0.78 over the past 6 years.
Assets per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- +2.4%
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2025, assets per share increased 12.7% year-over-year.
- Peak assets per share was recorded in FY2016.
- Lowest assets per share in the period was in FY2020.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score -13.34 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Assets per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $0.78 | +12.7% |
| FY2020 | $0.69 | -63.7% |
| FY2019 | $1.90 | +112.4% |
| FY2018 | $0.89 | -1.7% |
| FY2017 | $0.91 | -63.8% |
| FY2016 | $2.51 | - |
As of FY2025 · SEC 10-K · Updated Jun 28, 2026